6:25 PM
 | 
Jan 23, 2013
 |  BC Extra  |  Financial News

Auxilium planning $200M note deal

Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) said it plans to raise $200 million through the sale of convertible senior notes due 2018. Goldman Sachs; JPMorgan; Cowen; and RBC Capital Markets...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >